Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment

Tremendous data have been accumulated in the effort to understand chemoresistance of triple negative breast cancer (TNBC). However, modifications in cancer cells surviving combined and sequential treatment still remain poorly described. In order to mimic clinical neoadjuvant treatment, we first trea...

Full description

Bibliographic Details
Main Authors: Marie Winter, Samuel Meignan, Pamela Völkel, Pierre-Olivier Angrand, Valérie Chopin, Nadège Bidan, Robert-Alain Toillon, Eric Adriaenssens, Chann Lagadec, Xuefen Le Bourhis
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/6/1504